Discuss it at Diabetics World EMAIL
LISTS(click here)
01-Sep-96 07:12:28
Sb: Dangers of Hypo's
Fm: Bruce Beale 100345,3667
To: all
I am greatly indebted
to the Editor of Interactive Wall Street
Journal for authority to republish this very
important article. If you have the free
Microsoft Explorer 3. 00 you will be given
free access to the Wall Street Journal until
November. It comes with a quite exceptional
search engine. I commend both the WSJ and
MSIE 3. 00 to members. I am prepared to put
a copy of MSIE in our library for download
should I get any requests.
The DCCT ended very
suddenly and a couple of years early. some
of us never accepted the reasons given.
"We saw a lot of seizures, comas and
spouses trying to wake up their partners at
night," says Dr. Boyle, who was a
researcher in the study. The reasons are
starting to emerge had the study been
allowed to continue it would, in my opinion
have shown that tight control was a killer.
For parents of Type 1
children I want to make it absolutely clear
that Type 1 and Type 2 are totally separate
conditions. The onset of Type 2 is often
very slow and gradual and a great deal of
damage is done before the patient seeks
help. This is not as so of the type 1
patient where the onset is often very sudden
and life threatening leaving parents with an
irrational fear of hyper's and a curious
acceptance of lows which are much more life
threatening and dangerous.
It is not simply the
effects of tight control that has led to an
increase in deaths. It is the lack of a
suitable basal insulin on the market that is
the final killer together with the
assumption that tinkering around with the
dose before a meal is sensible. A change in
short term ill have an impact on the basal
dose and it will take a couple of days for
you to see the full effect of this. A change
in medication needs to be carefully
considered.
"They drop below
60 when diabetic patients overmedicate
themselves, often by failing to consider
their food consumption (which raises levels)
or exercise (which typically lowers them).
"
I am sorry but one of
the reasons for my being unable to read the
parents and Parenting Section is that I
daily read examples of the most dreadful
overmedication.
Patients Who Carefully
Manage Diabetes May Face Hidden Risks
Saturday 29 8 96
By JAMES S. HIRSCH Staff Reporter
of THE WALL STREET JOURNAL
Melinda
Lindsey tested her blood sugar up to six
times a day to keep her diabetes under tight
control. But on a quiet two-lane road in
Jeffersonville, Ind. , she lost control
completely. Last November, Ms. Lindsey's
white Oldsmobile barreled off the road and
crashed into a tree. Ms. Lindsey, who was
two months pregnant, was killed. Authorities
estimate she was traveling 73 miles an hour.
There were no skid marks. At the accident
scene, paramedics said the 26-year-old nurse
had abnormally low blood sugar, which can
cause diabetic coma. "She evidently
just passed out, and her foot hit the
accelerator," says her father, Clifford
Lindsey.
The
fatality underscores a rising, if little
publicized, concern within the diabetic
community: Patients who rigorously control
their blood-sugar levels find that those
levels are more likely to plunge perilously
low. "It's an enormous problem, and
it's becoming more common across the world
as people push harder to control their
diabetes," says Patrick Boyle, a
diabetes specialist at the University of New
Mexico Health Science Center in Albuquerque.
Diabetes
occurs when the pancreas stops making
insulin-producing cells, which moderate
blood-sugar swings. High blood sugar
typically results. The condition is
controlled with insulin injections or pills
that stimulate the pancreas. About eight
million Americans have been diagnosed with
the disease, and another eight million are
believed to have it but haven't been
diagnosed.
Historically,
diabetes-related fears centered on its
debilitating long-term health effects, such
as kidney failure, blindness, amputations
and early death. Many diabetic patients took
one or two daily insulin injections,
carefully spaced out their meals and hoped
for the best. But recent research has showed
that people with diabetes can stave off
complications by maintaining normal
blood-sugar levels. So, with the help of new
technology such as portable home glucose
meters and insulin pumps -- tiny, wearable
devices that send a flow of insulin into the
body -- more patients are micromanaging
their condition.
Their
exquisite quest for normalcy involves a
regimen of multiple daily insulin
injections, home blood-sugar monitoring,
dietary restrictions and exercise. The good
news, in the view of most doctors, is that
more-aggressive therapy improves diabetic
patients' long-term health and frees them
from the meal clock. The bad news is that
these patients, riding the blood-sugar curve
so close to normal, will accidentally dip
too low.
"The
whole spectrum of [blood sugars] is shifting
downward, but the dark side is that it
increases the rate of hypoglycemia," or
low blood sugar, says David Nathan of
Massachusetts General Hospital in Boston.
People
who aggressively manage their diabetes are
three times more likely than other diabetics
to suffer severe low-blood-sugar episodes,
defined as a patient being temporarily
disabled, according to the Diabetes Control
and Complications Trial, a landmark study
completed in 1993.
"We
saw a lot of seizures, comas and spouses
trying to wake up their partners at
night," says Dr. Boyle, who was a
researcher in the study.
Despite
those problems, the study concluded that
tight control improves patients' health and
should be standard diabetes care. Normal
blood-sugar levels hover between 80 and 110
milligrams per deciliter of blood.
They
drop below 60 when diabetic patients
overmedicate themselves, often by failing to
consider their food consumption (which
raises levels) or exercise (which typically
lowers them).
Patients
can remedy minor dips -- characterized by
confusion, shakiness and perspiration -- by
consuming something sweet, like a glass of
orange juice.
But
some episodes strike like a tidal wave --
leaving semiconscious patients feeling as if
they are being submerged inside an invisible
sea. They have only dazed moments to pull
themselves out. Most do, but others need
help -- and some don't make it at all.
Research
studies estimate between 4% and 13% of the
insulin-dependent diabetic patients who die
each year perish in hypoglycemic-related
accidents.
"What's
worrisome about these deaths is that they
are due to the treatment," notes Philip
Cryer, president of the American Diabetes
Association and a
member of the Washington University School
of Medicine in St. Louis. Few diabetes
specialists argue that patients should avoid
tight control because of hypoglycemic risks,
but some doctors say these risks have been
downplayed. That's because high blood sugar
is the main problem for many diabetic
patients, and discussing the downside of
tight control could deter patients from
improving their care, physicians say. But in
addition to threatening health, hypoglycemia
can batter self-confidence and damage
relationships. Last year,
Kimberly Chase had a low-blood-sugar seizure
after relying on a faulty home-glucose
meter; her husband revived her by giving her
orange juice. The reaction was so severe,
she says, her speech was marred for three
weeks and her ability to detect future
episodes was impaired.
The
35-year-old Ms. Chase, who teaches English
at a college in Seattle, says the stress
caused her marriage to break up. "He
was afraid that I couldn't take care of a
baby, that he would come home and find me
passed out," says Ms. Chase, who still
maintains tight control. "I'm afraid of
the long-term effects" of high blood
sugar, she says. Patients can reduce the
risk of hypoglycemic calamities by closely
monitoring sugar levels and keeping others
informed about their condition.
Chris
Crenshaw runs a landscaping company in
Nashville, Tenn. , and if he feels shaky
while working high in a tree, a glucose
meter is sent up to him on a rope.
The
31-year-old Mr. Crenshaw once had a close
call on a duck-hunting trip, when he
confused the signs of low blood sugar with
the excitement of the hunt. "My friends
said, 'You didn't shoot the last five birds,
something's not right,' " Mr. Crenshaw
says. "They gave me a glucose tablet.
"Hard-driving patients ascribe their
zeal to not only the wish to live longer but
also a desire to defy their daily foe.
Michael
Zarrick, a 35-year-old manufacturers'
representative in Kansas City, decided to go
on the insulin pump last year when he feared
his kidneys were going bad. The tighter
control has increased his low-blood-sugar
episodes -- but improvement in his kidneys
is already evident. "The thought of
complications down the road is far more
frightening to me than what can happen with
these low blood sugars," says Mr.
Zarrick, who has had diabetes since he was
10 years old. "I won't let it beat
me."
My reply:
Gentlemen:
As a long-term
diabetic having been on insulin therapy for
over 43 years and as a devoted reader of the
Journal, I feel compelled to respond to your
recent article concerning the dangers of
intensive therapy and of the undisclosed
dangers of "human" insulin.
For the past 6. 5
years, I have owned and operated the
Diabetes & Hypoglycemia Forum on
Compuserve Information Service.
Having been maligned,
cursed, ridiculed and libeled for my
position that the DCCT was a tremendous
waste of taxpayer dollars that was destined
to kill a great many diabetics and innocent
non-diabetics, it is almost unpleasant to
finally read the admission that I was
correct.
The 340% risk of
severe hypoglycemia was known BEFORE the
main study was run. The patients in the
study were deliberately selected to be those
LEAST prone to hypoglycemia and most of the
tremendous FREE medical care they got was
devoted to avoiding hypoglycemia. The
study's fallacious conclusion that the risk
of near instant death from hypoglycemia or
resultant trauma and the risk of killing
others while in shock is outweighed by
avoiding the risks of potentially blinding
retinopathy, potential kidney failure and
possible nerve damage in the distant future
is simply silly on its face.
In 1989, you ran an
article indicating that "human
insulin" might be part of the problem
which diabetics are experiencing and once we
are able to properly read the results of the
DCCT, this too will be made apparent as the
preponderance of scientific evidence already
shows that there is absolutely NO benefit to
human insulin and that properly measured,
there is an extreme risk of going into
severe hypoglycemic shock as a direct result
of using human insulin. The combination of
using human insulin and attempting
"intensive therapy" at the same
time is clearly not in the interests of any
diabetic.
It is time for Lilly,
Novo and the entire medical community to
wake up and smell the coffee.
Listen to the
diabetics and give us back our badly needed
animal source insulins. Admit the mistake
and waste of $176,000,000 to $300,000,000 in
the silliness of the DCCT and lets work to
make living with diabetes a possibility and
refresh the search for promised cures.
WE the diabetics of
the US, in whose name American Diabetes
Association and Juvenile Diabetes Foundation
collect funds for research and care, must,
like the students of Galludet, be heard.
Precious research money must NEVER be wasted
like this again, and the truth about human
insulin must be told.
I have enclosed a copy
of cites on the risks of human insulin for
your perusal.
Sincerely,
/s
One of the 16 million
diabetics whose disease eats $1 in every $7
US healthcare dollars spent.